Cost-effectiveness of Basal Flow Sevoflurane Anaesthesia Using the Komesaroff Vaporizer inside the Circle System

After ethics committee approval, 51 consenting ASA physical status 1 or 2 adult patients were given basal flow sevoflurane anaesthesia using fresh gas flows of 150 to 300 ml.min-1 oxygen. A Komesaroff vaporizer was placed on the inspiratory limb of the circle system. Basal flows were introduced immediately following intravenous induction of anaesthesia. The vaporizer was set to deliver the maximum concentration until the inspired sevoflurane concentration (FSI) reached 3%. The dial was then adjusted to maintain the FSI at 3%. After every 60 minutes, the circuit was washed out with 100% oxygen at a flow rate of 10 l.min-1 for one minute.

The FSI reached 3% after an average of 8.5 (3.8) [mean (SD)] minutes. The trends in FSI and the expired sevoflurane concentrations were significantly different (P<0.05) between the mechanically ventilated patients (n=21) and the spontaneously ventilating patients (n=30) and demonstrated a more gradual build-up in the former group. The consumption of sevoflurane was found to be 9.2 (2.8) ml.h-1. This represented a 52.5% cost saving over the clinical application of the Mapleson's ideal fresh gas flow sequence for low-flow anaesthesia.

An audit of anaesthetic fresh-gas flow rates and volatile anaesthetic use in a teaching hospital

AIM

The large number of anaesthetics administered means that the total cost to a hospital of inhalational anaesthetic agent such as isoflurane or sevoflurane can be considerable. The total anaesthetic gas flow is a major determinant of the use of these agents. Modern anaesthetic machines and monitoring facilitate reduced gas flows, which can significantly reduce wastage of these anaesthetic agents. The purpose of this study was to audit gas flow rates and volatile anaesthetic use.

METHODS

We audited gas flows and choice of anaesthetic agent over two one-month periods in one theatre at Christchurch Hospital. Data were collected directly from the anaesthetic machine using a computer. The second study period was clearly advised and followed widespread discussion of results from the first study period.

RESULTS

Average fresh-gas flow was approximately 2 l/min (Month 1 = 2.0 l/min, Month 2 = 2.1 l/min). Use of the more expensive agent, sevoflurane, increased but gas flows with this agent decreased.

CONCLUSIONS

Given the low flows used, the small difference between study periods was not surprising. The gas flows recorded represent responsible use of anaesthetic agents and are at least as good as flows achieved in previous studies that employed various methods to encourage their reduction.

Measuring the costs of inhaled anaesthetics

The cost of inhalation anaesthesia has received considerable study and is undoubtedly reduced by the use of low fresh gas flows. However, comparison between anaesthetics of the economies achievable has only been made by computer modelling. We have computed anaesthetic usage for MAC-equivalent anaesthesia with isoflurane, desflurane, and sevoflurane in closed and open breathing systems. We have compared these data with those derived during clinical anaesthesia administered using a computer-controlled closed system that measures anaesthetic usage and inspired concentrations. The inspired concentrations allow the usage that would have occurred in an open system to be calculated. Our computed predictions lie within the 95% confidence intervals of the measured data. Using prices current in our institution, sevoflurane and desflurane would cost approximately twice as much as isoflurane in open systems but only about 50% more than isoflurane in closed systems. Thus computer predictions have been validated by patient measurements and the cost saving achieved by reducing the fresh gas flow is greater with less soluble anaesthetics.

Air contamination of a closed anesthesia circuit

Closed-circuit anesthesia (CCA) has certain advantages such as decreased cost, decreased anesthetic gas pollution, improved inhalational gas humidity and temperature in comparison to conventional inhalational anesthesia using a high fresh gas flow, i.e. more than 2 L x min(-1), with a semi-closed breathing circuit. The main disadvantage of CCA is the possibility of hypoxic anesthetic gas delivery. This potentially lethal situation is caused by an insufficient oxygen flow rate for the body metabolism or by the accumulation of inactive gas, usually nitrogen, within the breathing circuit in spite of a sufficient oxygen concentration in the fresh gas supply to the breathing circuit. In the latter case, the accumulation of inactive gas may also lead an increased risk of awareness because of its dilution effect on the concentrations of inhalational anesthetics. We herein present a case of air contamination of the breathing circuit through a sampling line of an anesthetic gas monitor. The air caused a decrease in the oxygen concentration during closed circuit anesthesia.

[Minimal-flow anesthesia in the dog]

Many veterinary practices possess an anesthetic machine with a rebreathing system, and therefore the facility to induce anesthesia under more cost-effective reduced fresh gas flow conditions in a semi-closed system. However, as the fresh gas flow is frequently far too high, the rebreathing element is used rarely or not at all, making the anesthesia unnecessarily expensive. The relationships between the fresh gas setting and the final concentrations of expired air are discussed, and experience in 53 dogs with minimal flow anesthesia (500 ml/min), an extreme variant of anesthesia induction using a semi-closed system with minimal excess gas volume and a high proportion of rebreathed gas, is described.

Priming of anesthesia circuit with xenon for closed circuit anesthesia

Xenon is an inert gas with a practical anesthetic potency (1 MAC = 71%). Because it is very expensive, the use of closed circuit anesthesia technique is ideal for the conduction of xenon anesthesia. Here we describe our methods of starting closed circuit anesthesia without excessive waste of xenon gas. We induce anesthesia with intravenous agents, and after endotracheal intubation, denitrogenate the patient for approximately 30 min with a high flow of oxygen. This is done to minimize accumulation of nitrogen in the anesthesia circuit during the subsequent closed-circuit anesthesia with xenon. Anesthesia is maintained with an inhalational anesthetic during this period. Then, we discontinue the inhalation agent and start xenon. For this transition, we feel it is unacceptable to simply administer xenon at a high flow until the desired end-tidal concentration is reached because it is too costly. Instead we set up another machine with its circuit filled in advance (i.e., primed) with at least 60% xenon in oxygen and switch the patient to this machine. To prime the circuit, we push xenon using a large syringe into a circuit, which was prefilled with oxygen. Oxygen inside the circuit is pushed out before it is mixed with xenon, and xenon waste will thus be minimized. In this way, we can achieve close to 1 MAC from the beginning of xenon anesthesia, and thereby minimize the risk of light anesthesia and awareness during transition from denitrogenation to closed-circuit xenon anesthesia.

Economic analysis and pharmaceutical policy: a consideration of the economics of the use of desflurane

Several factors have to be considered in determining the cost of applying a new inhalational anaesthetic such as desflurane into clinical practice. Factors beyond the immediate control of the anaesthetic practitioner include the price set by the manufacturer (although this may be influenced by economic and political pressures), and the physical-pharmacological properties of the anaesthetic (e.g. vaporization, potency, solubility). The anaesthetic practitioner can minimise cost by applying lower inflow rates. Lower solubility (and hence lower uptake) provides a greater economy at lower inflow rates than does higher solubility. Furthermore, lower solubility permits the use of lower inflow rates with greater precision to the control of anaesthesia, and greater ease of application. At present unit prices, the cost of desflurane approximately equals that of isoflurane when a 1 l.min-1 inflow rate is used. The use of lower inflow rates presupposes that such rates do not allow the production of toxic compounds in recirculating gases. Modern equipment makes low-flow anaesthesia reliable and easy to control, and as desflurane is not degraded by the standard carbon dioxide absorbents, its use in low-flow systems is effective and economical. These cost considerations do not take into account the savings that may result from a more rapid recovery from anaesthesia, nor do they take into account the increased expense of capital equipment needed to apply a new anaesthetic.

[Anesthesia with low fresh gas flow in clinical routine use]

Anaesthesia in low-flow techniques gains increasing interest. The possibility of cost reduction, widespread use of highly developed anaesthesia machines and monitors, and introduction of two new fluorinated inhalational anaesthetics with low solubility in human tissues encourage the use of low-flow anaesthesia techniques. Further advantages are improved climatisation of breathing gas and estimation or even measurement of the important parameter "oxygen consumption". The anaesthesia machines and inhalational anaesthetics currently available allow a safe use of low-flow techniques if safety requirements are complied with (tight circle system, monitoring of: inspired oxygen concentration, minute ventilation, airway pressure, transcutaneous oxygen saturation). Low-flow anaesthesia techniques using a fresh gas flow rate of 1 l/min can be performed with almost every anaesthesia machine. However, the use of multigas monitors, analyzing most parts of the breathing gas, facilitates the use of low-flow techniques. Multigas monitors and anaesthesia machines equipped with intermittent fresh gas delivery are recommended for the use of fresh gas flow rates close to the metabolic rate. Because of its physicochemical properties the new inhalational anaesthetic desflurane offers advantages for the use in low-flow anaesthesia techniques.

[Anesthetic gas consumption and costs in a closed system with the PhysioFlex anesthesia equipment]

A marked decrease in both personal and environmental pollution with anaesthetic gases as well as in costs is possible with anaesthesia machines which can be run with a low fresh gas flow (FGF) [9]. Low-flow anaesthesia can be performed with appropriately equipped circle systems, although strongly reduced FGF minimises the control of depth of anaesthesia and gas concentrations. Microprocessor-controlled feedback systems allow the utilisation of closed-circuit systems throughout the whole duration of anaesthesia, maintaining full anaesthetic control [3,5]. The aim of this investigation was to determine the costs resulting from gas consumption and clinical suitability of the recently marketed PhysioFlex anaesthesia machine. METHODS. We used a PhysioFlex (Physio, Hoofdorpp, Netherlands) in a series of 15 routine otorhinolaryngological interventions. After induction with thiopentone and suxamethonium, general anaesthesia was maintained with nitrous oxide in 30% oxygen and isoflurane and supplemented with fentanyl and atracurium. The expenditure of anaesthetic gases was recorded during a total of 61 h and 27 min and differentiated into its components. Anaesthetic gas uptake and costs were compared with different breathing systems (low-flow anaesthesia, semiclosed system and non-rebreathing system) under similar clinical conditions. RESULTS. The average minute volume was 6.84 (+/- 1.17) l and the expiratory isoflurane concentration was 0.91% (+/- 0.14%) (Table 1). These settings resulted in an oxygen expenditure of 27.9 (+/- 8.46) l/h with total costs of SFr. 0.04, nitrous oxide 11.9 (+/- 5.4) l/h and 0.27, isoflurane 3.9 ml/h and SFr. 5.42. In contrast, other breathing systems in analogous settings resulted in greater costs by a factor of 0.77 for low-flow anaesthesia (FGF 1 l/min), 2.47 for a semiclosed system (FGF 3 l/min) and 5.63 for a valve-controlled non-rebreathing system (FGF 6.84 l/min) (Table 2). DISCUSSION. The emission of anaesthetic gases can be lowered by measures that avoid unintended gas fallout, the application of filters, scavenging systems and efficient air circulation in operation and recovery rooms [8]. Above all, the use of the lowest possible FGF is advantageous for the patient insofar as better conditioned breathing gases are available, and economic and environmental effects are more significant (Table 3). With the method of quantitative anaesthesia as performed by the PhysioFlex, it is now possible to reduce gas expenditure according to the requirements of the patient as well as maintaining full control of anaesthesia depth. Simultaneously, multiple secured feedback control systems guarantee adequate monitoring and storage of respiratory and metabolic parameters. The duration of nitrous oxide wash-out can be a problem, in particular, when a changeover to O2/air is required.

[Closed anesthetic systems]

Anaesthesia with closed anaesthetic systems demands knowledge of the physiology of the patients and of how the various anaesthetic gases behave in the organism as only the gases which the patients produces and absorbs are eliminated and replaced. The system is educational as it provides knowledge of the genuine absorption of oxygen and anaesthetic gases. The method is favourable to the environment as only the gases which are used are supplied and it is thus economical in use although investment in monitoring equipment is necessary. In practice, induction and waking of the patient are complicated with this system and it requires an anaesthetist who constantly adjusts the gases in the circuit.

[Low-flow anesthesia systems]

At present, when economy and environment receive high priority, the ideal anaesthesia system with inhalation anaesthetics is a closed circle system in which only the gases which the patient consumes or produces are replaced or eliminated. Low-flow (LF) anaesthesia in which the fresh gas flow which is employed in a closed system, provides a stable system compares with closed anaesthesia systems. Compared with open systems and circler systems with considerable fresh gas flow, the LF system provides advantages as regards economy, environment and exposure of staff to inhalation anaesthetics. The special conditions involved in LF anaesthesia are described in detail with the hope that the method will obtain more widespread distribution than is the case in Denmark today. If greater safety under anaesthesia is desired, eg by monitoring the concentrations of CO2, O2 and inhalation anaesthetics which the patients inspire and expire, this monitoring equipment can be financed by introduction of LF anaesthesia.

[Closed circuit inhalation anesthesia. Consumption and cost]

Closed circuit anaesthesia (CCA) and minimal flow anaesthesia diminish inhalatory anaesthetic consumption. Consumption of inhalatory anaesthesia was calculated using two different techniques: CCA and "non rebreathing" system. Costs were compared on the basis of the official list price. The CCA allowed for reduced consumption at lower costs. The resulting annual savings are equal to one third of the total price of the whole apparatus with its complementary monitoring and control systems.

An alternative strategy for infection control of anesthesia breathing circuits: a laboratory assessment of the Pall HME Filter

Contaminated breathing systems have been responsible for nosocomial upper respiratory tract and pulmonary infections in patients undergoing general anesthesia. The current infection control guidelines for anesthesia breathing circuits require single-patient use or high-level disinfection of breathing tubes, y-connector, and reservoir bag. An alternative infection control strategy has been suggested that incorporates placement of a microbial filter downstream from the y-connector between the circuit and the patient. This laboratory study assessed the capacity of the Pall HME Filter as a bidirectional barrier to transmission of bacteria between the y-connector of an anesthesia circle breathing system and a test lung. The investigators modified a sterile circle system to allow aerosolization of a suspension of 10(9) Micrococcus luteus over 5 h into the inspiratory limb proximal to the y-connector or downstream from the filter into the test lung. Cultures indicated that the Pall HME Filter placed between the y-connector and the test lung completely prevented transmission of bacteria in both directions. The results of this study suggest that the Pall HME Filter could be used as an effective microbial barrier between the anesthesia circle breathing system and the patient as part of an alternative strategy for infection control.

[Use of isoflurane in a closed-circuit. Economic advantages]

The present study was designed to assess whether isoflurane requirement was significantly affected by fresh gas flow in a closed-circuit system. Sixty patients scheduled for orthopaedic procedures were randomly assigned into three groups. In group A (n = 20), anaesthesia was conducted with a fresh gas flow of 482.5 +/- 186.6 ml X min-1, corresponding to the patient's metabolic demand. In group B (n = 20), the fresh gas flow was 2000 ml X min-1. In group C (n = 20), it was adjusted to the ventilation minute, i.e. 7145 +/- 986 ml X min-1. Artificial ventilation was conducted using a tidal volume of 10 ml X kg-1 and a rate of 10 to 12 c X min-1. Anaesthesia was induced after 10 min denitrogenation with fentanyl (4 micrograms X kg-1), thiopentone (4 mg X kg-1) and vecuronium (0.1 mg X kg-1). FIO2 was then brought to 0.5 in nitrous oxide and was monitored continuously using a polarographic oxymeter. Liquid isoflurane was injected in the expiratory limb of the circuit using an electrical syringe driver. Alveolar concentration of isoflurane was set at 0.92 vol. % according to Lowe and Ernst. Statistical analysis was carried out using Student's test for means. Anaesthesia lasted 138 +/- 88.3 min in group A, 125.5 +/- 45.1 min in group B and 146.5 +/- 50 min in group C, no difference being significant.(ABSTRACT TRUNCATED AT 250 WORDS)